Monopar Therapeutics Inc (MNPR) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Monopar Therapeutics Inc (MNPR) Company Statistics | The Fly

Monopar Therapeutics Inc

· MNPR

Dashboard

Financials

Ratios

Valuation

Statistics

536.974 M

-0.41%

General

Market Cap: $536.97M
Enterprise Value: $481.06M
Shares Outstanding: 6,700,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -13.22%
ROE: -13.08%
ROIC: -16.89%
Current Ratio: 33.56
Debt-to-Equity: 0.00
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 4.08
EV/EBITDA: -26.00

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $22.12M
Operating Income: -$22.12M
Net Profit: -$17.84M

Balance Sheet

Cash and Equivalents: $52.76M
Working Capital: $130.75M
Total Assets: $134.98M
Net Debt: -$52.65M
Total Liabilities: $4.12M
Total Equity: $130.85M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$3.26B
Cash Flow from Investing: $4.05B
Cash Flow from Financing: -$555.58M
Free Cash Flow: -$3.26B
Capital Expenditures: $0